Novartis reported $4.06B in Pre-Tax Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Alcon AG ALC:SW USD 307M 45M
Almirall ALM:SM EUR 13.9M 14.3M
AstraZeneca AZN:LN USD 3.09B 52M
Biogen BIIB:US USD 821M 53.8M
Fresenius FRE:GR EUR 746M 17M
Fresenius Medical Care FME:GR EUR 397M 50M
Genmab GEN:DC DKK 3.27B 783M
GlaxoSmithKline GSK:LN GBP 2.43B 602M
Hikma Pharmaceutical HIK:LN USD 251M 28M
Johnson & Johnson JNJ:US USD 8.07B 98M
Merck MRK:GR EUR 1.29B 108M
Novartis NOVN:VX USD 4.06B 72M
Orion ORNBV:FH EUR 244.6M 161.5M
Pfizer PFE:US USD 10.67B 3.11B
Philips PHIA:NA EUR 65M 218M
Regeneron Pharmaceuticals REGN:US USD 1.45B 140.6M